SCHEDULE 13D

Item 3 is hereby amended and restated to read as follows: The Shares purchased by JCP Partnership and held in the JCP Accounts were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business). The aggregate purchase price of the 776,564 Shares owned directly by JCP Partnership is approximately $3,687,481, including brokerage commissions. The aggregate purchase price of the 1,084,104 Shares held in the JCP Accounts is approximately $5,426,197, including brokerage commissions. Mr. Pappas has acquired 83,608 Shares upon the vesting of certain restricted stock units ("RSUs") that were awarded to him in his capacity as a director of the Issuer. The Shares purchased by Jumana Capital were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business). The aggregate purchase price of the 1,667,906 Shares directly owned by Jumana Capital is approximately $8,429,773, including brokerage commissions. Mr. Martin has acquired 83,608 Shares upon the vesting of certain RSUs that were awarded to him in his capacity as a director of the Issuer.

Item 4 is hereby amended to add the following: On October 23, 2026, each of Messrs. Pappas and Martin notified the Issuer of his resignation from the Board and all committees of the Board, effective as of October 23, 2026. Also on October 23, 2026, JCP Management and Jumana Capital each executed a waiver (the "Cooperation Agreement Waivers") to the Cooperation Agreement, dated as of December 3, 2024 and amended on February 13, 2026 (the "Cooperation Agreement"). Pursuant to the Cooperation Agreement Waivers, the Reporting Persons irrevocably waived any right to have a Replacement Investor Designee (as defined in the Cooperation Agreement) appointed to the Board. The foregoing description of the Cooperation Agreement Waivers does not purport to be complete and is qualified in its entirety by reference to the Cooperation Agreement Waivers, which are attached as Exhibit 99.2 and Exhibit 99.3 hereto, and are incorporated herein by reference.

Item 5(a) is hereby amended and restated to read as follows: The aggregate percentage of Shares reported owned by each person named herein is based upon 18,903,752 Shares outstanding as of August 5, 2026, which is the total number of Shares outstanding as reported in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 12, 2026. As of the date hereof, JCP Partnership beneficially owned 776,564 Shares, constituting approximately 4.1% of the Shares outstanding. JCP Partners, as the general partner of JCP Partnership, may be deemed the beneficial owner of the 776,564 Shares owned by JCP Partnership, constituting approximately 4.1% of the Shares outstanding. JCP Holdings, as the general partner of JCP Partners, may be deemed the beneficial owner of the 776,564 Shares owned by JCP Partnership, constituting approximately 4.1% of the Shares outstanding. As of the date hereof, 1,084,104 Shares were held in the JCP Accounts, constituting approximately 5.7% of the Shares outstanding. JCP Management, as the investment manager of JCP Partnership and the JCP Accounts, may be deemed the beneficial owner of the (i) 776,564 Shares owned by JCP Partnership and (ii) 1,084,104 Shares held in the JCP Accounts, constituting approximately 9.8% of the Shares outstanding. As of the date hereof, Mr. Pappas directly beneficially owned 83,608 Shares, constituting approximately 0.4% of the Shares outstanding. Mr. Pappas, as the managing member of JCP Management and sole member of JCP Holdings, may be deemed the beneficial owner of the (i) 776,564 Shares owned by JCP Partnership and (ii) 1,084,104 Shares held in the JCP Accounts, which, together with the Shares he beneficially owns directly, constitutes an aggregate of 1,944,276 Shares, constituting approximately 10.3% of the Shares outstanding. As of the date hereof, Jumana Capital beneficially owned 1,667,906 Shares, constituting approximately 8.8% of the Shares outstanding. As of the date hereof, Mr. Martin directly beneficially owned 83,608 Shares, constituting approximately 0.4% of the Shares outstanding. Mr. Martin, as the Manager of Jumana Capital, may be deemed the beneficial owner of the 1,667,906 Shares owned by Jumana Capital, which, together with the Shares he beneficially owns directly, constitutes an aggregate of 1,751,514 Shares, constituting approximately 9.3% of the Shares outstanding.

Item 5(c) is hereby amended and restated to read as follows: There have been no transactions in the securities of the Issuer by the Reporting Persons during the past 60 days, other than the acceleration of the vesting of certain RSUs as described in Item 6 below.

Item 6 is hereby amended to add the following: On October 23, 2026, each of JCP Management and Jumana Capital executed a Cooperation Agreement Waiver as defined and described in Item 4 above, which are attached as Exhibit 99.2 and Exhibit 99.3 hereto, and are incorporated herein by reference. Mr. Pappas was awarded an aggregate of 83,608 RSUs in his capacity as a director of the Issuer, all of which have vested as of the date hereof. In connection with Mr. Pappas' resignation from the Board, the Issuer accelerated the vesting of 31,662 RSUs as of such date. Mr. Martin was awarded an aggregate of 83,608 RSUs in his capacity as a director of the Issuer, all of which have vested as of the date hereof. In connection with Mr. Martin's resignation from the Board, the Issuer accelerated the vesting of 31,662 RSUs as of such date. On October 27, 2026, the Reporting Persons executed a Termination of Group Agreement, thereby terminating that certain Group Agreement, dated September 23, 2024. A copy of the Termination of Group Agreement is attached as Exhibit 99.1 hereto and is incorporated herein by reference. On October 27, 2026, JCP entered into a Joint Filing Agreement pursuant to which the members thereof agreed to the joint filing on behalf of each of them of statements on Schedule 13D with respect to the securities of the Issuer to the extent required by applicable law. A copy of the Joint Filing Agreement is attached hereto as Exhibit 99.4 and is incorporated herein by reference.

Item 7 is hereby amended to add the following exhibits: 99.1 - Termination of Group Agreement, dated October 27, 2026. 99.2 - JCP Cooperation Agreement Waiver, dated October 23, 2026. 99.3 - Jumana Cooperation Agreement Waiver, dated October 23, 2026. 99.4 - Joint Filing Agreement, dated October 27, 2026.